No treatment differences between BC and placebo groups following five days of treatment consumption and MWM training were measured for both MAO-A (p = 0.866, pa = 0.866) and MAO-B (p = 0.459, pa = 0.574; Figure S2). This evidence concerns the gene MAOB and breast cancer.